TGFB1 and neoplasm: Our study adds to the growing body of evidence regarding the potential range of mechanisms that can mediate anti-tumor effects of metformin in concert with ARATs, including, for instance, the recent demonstration of metformin sensitizing PC cells to enzalutamide via recruitment of STAT3/TGFb signaling [47].